Released: 6-Sep-2005 1:40 PM EDT
Scientist First to Discover How to Overturn Suppressive Immune Response
Cancer Research Institute

Results from a research study supported by the Cancer Research Institute indicates that the suppressive immune tendencies of CD4+ regulatory T cells can be regulated, thus overcoming a huge hurdle faced when crafting a cancer vaccine.

5-May-2006 2:20 PM EDT
Network Seeks Genetic Cause of Innate Cancer Immunity
Cancer Research Institute

The Cancer Research Institute has established a unique collaboration with three other major U.S. research institutions that will work together to unlock the molecular and genetic mysteries behind Zheng Cui's SR/CR mouse's remarkable cancer immunity.

Released: 30-May-2006 4:45 PM EDT
Awards Dinner Honors Cervical Cancer Vaccine Creator & Others
Cancer Research Institute

The Cancer Research Institute announces the 2006 Coley and Grace Award winners. Coley Award winners include Dr. Harald zur Hausen, Dr. Ian Frazer, Dr. Bruce Beutler, and Dr. Shizuo Akira. Philanthropist Julian H. Robertson, Jr., will receive the Grace Award. The annual gala takes place June 27, 2006, at the Rainbow Room in New York City's Rockefeller Center.

Released: 15-Aug-2006 12:00 PM EDT
Ovarian Cancer Survivor’s Immune System Keeping Her Alive
Cancer Research Institute

After surgery and six months of chemotherapy brought her metastatic ovarian cancer under control, Christine Sable sought less toxic ways to keep her cancer from coming back. She enrolled in an ovarian cancer vaccine study and, three years later, is still cancer free. Her immune system, she says, is keeping her alive.

Released: 20-Sep-2006 6:35 PM EDT
A Promising New Vaccination Strategy for Late-Stage Melanoma
Cancer Research Institute

Cancer Vaccine Collaborative scientists announce that results from a study of a new vaccination strategy indicate the vaccine had a favorable impact on disease progression in late-stage melanoma patients. The vaccine is composed of recombinant fowlpox and vaccinia viruses engineered to express the Cancer-Testis antigen NY-ESO-1.

Released: 22-May-2007 5:05 PM EDT
Cancer Research Institute Announces 2007 Grace and Coley Award Winners
Cancer Research Institute

Cancer Research Institute honors scientific, philanthropic, and corporate leaders who have made significant contributions to the fight against cancer at its 21st annual awards dinner in New York City on June 26, 2007.

Released: 18-Jun-2007 4:00 PM EDT
“Drive Against Prostate Cancer” Mobile Screening Vehicle to be Showcased at Annual CRI Awards
Cancer Research Institute

The nationally touring "Drive Against Prostate Cancer" mobile medical screening vehicle will be on display for public tour during the Cancer Research Institute's 21st annual awards dinner, Tuesday, June 26, from 6 p.m. to 7 p.m., outside New York City's Rainbow Room at Rockefeller Plaza.

Released: 20-Aug-2007 12:35 PM EDT
Immunological Research Organizations Announce Intent to Merge
Cancer Research Institute

The Cancer Research Institute, Inc. and The Irvington Institute for Immunological Research, two leading private immunological research funding organizations headquartered in New York City, have announced today their intention to merge.

Released: 3-Oct-2007 8:40 AM EDT
Cancer & HIV Vaccine Researchers to Meet to Share Data, Lessons Learned
Cancer Research Institute

Cancer and HIV vaccine researchers from around the world will gather for a three-day conference in New York City October 4-6, 2007, along with representatives from industry and health research funding organizations to share and discuss data from the latest clinical and laboratory studies aimed at developing preventive and therapeutic vaccines for both diseases.

Released: 31-Oct-2007 3:25 PM EDT
Merger Approved Between Cancer Research Institute and the Irvington Institute for Immunological Research
Cancer Research Institute

Cancer Research Institute, Inc., and the Irvington Institute for Immunological Research, two leading nonprofit immunology research-funding organizations, merge.

16-Nov-2007 1:25 PM EST
Immune System Controls Cancer, Promotes Tumor Dormancy
Cancer Research Institute

Cancer Research Institute supported scientists have proven that dormant cancer cells are actively kept in check by the immune system, while those that escape go on to develop into clinically detectable tumors. A paper online in this week's Nature identifies a crucial stage in the battle, at which point immune defenses stall the expansion of cancer cells that may have managed to dodge past early immunosurveillance.

Released: 28-Jan-2008 12:00 AM EST
Cancer Vaccine Consortium and Cancer Vaccine Collaborative Unite under the Cancer Research Institute
Cancer Research Institute

Two global cancer vaccine initiatives comprising industrial and academic efforts have united in close cooperation under the nonprofit Cancer Research Institute to establish a unified voice in the cancer vaccine field, providing a major new resource to academia, industry, and governmental agencies involved in cancer vaccine discovery and development.

Released: 27-May-2008 12:25 PM EDT
Cancer Research Institute Announces 2008 Grace and Coley Award Winners
Cancer Research Institute

On June 17, 2008, the Cancer Research Institute (CRI) will host its 22nd Annual Awards Dinner at The Rainbow Room in New York City. More than 300 guests are expected to attend the black-tie dinner, at which CRI will honor philanthropic and corporate leaders and scientists who have made significant contributions to the fight against cancer.

Released: 31-Jul-2008 4:00 PM EDT
Cancer Research Institute Names Sixteen New Postdoctoral Fellows
Cancer Research Institute

The Cancer Research Institute, a nonprofit charitable organization dedicated to advancing immunology to conquer cancer, announced that the Fellowship Review Committee of the Institute's Scientific Advisory Council, with the approval of the Institute's Board of Trustees, has named 16 new postdoctoral fellows from its April 2008 application round, awarding more than $2.3 million in research funding through the Irvington Institute Fellowship Program of the Cancer Research Institute.

Released: 4-Aug-2008 3:45 PM EDT
Cancer Research Institute Names Six New Investigator Award Winners
Cancer Research Institute

The Cancer Research Institute, a nonprofit charitable organization dedicated to advancing immunology to conquer cancer, announced that the Investigator Award Review Committee of the Institute's Scientific Advisory Council, with the approval of the Institute's Board of Trustees, has named six new investigators from its March 2008 application round, awarding $1.2 million in research funding.

Released: 10-Sep-2008 8:55 AM EDT
Cancer Immunology & Immunotherapy 2008: From Discovery to Development to Drug
Cancer Research Institute

Immunologists and tumor immunologists from around the world will gather for three days in New York City next week at the Millennium Conference Center near Times Square for the Cancer Research Institute's 16th International Cancer Immunotherapy Symposium to share the latest data from laboratory and clinical studies of the immune system's role in cancer development and control, and discuss promising immune-based therapies that capitalize on new knowledge of cancer's immune escape mechanisms and how they can be modulated to control the disease.

Released: 15-Jan-2009 4:30 PM EST
New York's Cancer Vaccine Collaborative is Named Finalist for National Nonprofit Collaboration Prize
Cancer Research Institute

The Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd (LICR), has been named one of eight finalists for The Collaboration Prize, a national cash award of $250,000 presented to an outstanding model of nonprofit collaboration.

Released: 29-Apr-2009 11:20 AM EDT
PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy
Cancer Research Institute

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in Chicago. This milestone achievement for the field of tumor immunology heralds the advent of a new dawn in cancer therapy, say experts, where immune-based agents will form a new, fourth modality to complement today's standard chemical, radiological, and surgical therapies.

Released: 10-May-2009 10:00 PM EDT
NYC Society Goes "Through the Kitchen" for Cancer Research Institute
Cancer Research Institute

The Cancer Research Institute hosted the 27th annual "Through the Kitchen" Dinner at The Four Seasons Restaurant on May 3, 2009, where 225 guests helped raise $505,000 for the organization. Broadcast journalist Perri Peltz and her husband Eric Ruttenberg hosted the memorable evening along with event co-chairs Margaret and Andrew Paul and Lara and Remy Trafelet. Sotheby's Jamie Niven drove a very successful live auction that brought in $160,000 to top off the $345,000 in ticket sales.

Released: 11-May-2009 4:50 PM EDT
13 Young Research Scientists Named Cancer Research Institute Fellows
Cancer Research Institute

The Fellowship Review Committee of the Cancer Research Institute's Scientific Advisory Council, with the approval of the Institute's Board of Trustees, has named 13 new postdoctoral fellows from its October 2008 application round, awarding more than $1.89 million in research funding through the Irvington Institute Fellowship Program of the Cancer Research Institute.

Released: 29-May-2009 4:25 PM EDT
2009 Grace and Coley Award Winners Announced
Cancer Research Institute

The 23rd Annual Awards Dinner of the Cancer Research Institute will take place June 11, 2009, at the St. Regis in New York City. Scientific and corporate leaders will be honored for their contributions to immunology, tumor immunology, and cancer therapies.

Released: 7-Aug-2009 9:00 AM EDT
Expert Available for Commentary on Recent FDA Analysis of TNF Blockers
Cancer Research Institute

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a tumor immunologist, is available for comment.

Released: 10-Aug-2009 12:00 AM EDT
Cancer Research Institute Benefits from NYC Midsummer Social for Young Philanthropists
Cancer Research Institute

Even in a tight economy, young people in their 20s and 30s will still give to important charitable causes. More than 320 such "young philanthropists" turned out for a Cancer Research Institute benefit at one of Manhattan's premiere nightclubs on August 6, 2009.

Released: 13-Aug-2009 9:00 AM EDT
Cancer Vaccine Produced at Non-Commercial Facility Enters Clinical Trials
Cancer Research Institute

The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).

Released: 21-Sep-2009 12:45 PM EDT
Stenbeck Foundation Makes $1 Million Gift to Cancer Research Institute for Ovarian Cancer Research
Cancer Research Institute

The Stenbeck Foundation, a family foundation established in 2008 by the heirs of Swedish industrialist Jan Stenbeck, has made a generous gift of $1 million to the Cancer Research Institute (CRI) to support the Institute’s ovarian cancer research efforts.

Released: 29-Sep-2009 5:05 PM EDT
Symposium to Highlight Strategies to Overcome Cancer Immunosuppression During Treatment
Cancer Research Institute

Cancer vaccine researchers and immunologists from academia and industry will meet for three days in New York City at a Cancer Research Institute symposium, "Control of Cancer Immunosuppression: The Challenge for Cancer Vaccine Development."

Released: 6-Oct-2009 4:35 PM EDT
Cancer Research Institute Announces Winner of 2009 Frederick Alt Award for New Discoveries in Immunology
Cancer Research Institute

The Cancer Research Institute, Inc. (CRI) has announced that Anjana Rao, Ph.D., professor of pathology at the Harvard Medical School in Boston, MA, is the winner of the Cancer Research Institute 2009 Frederick W. Alt Award for New Discoveries in Immunology.

   
Released: 20-Oct-2009 1:50 PM EDT
U.S. and European Immunologists Launch New Initiative to Improve Reliability and Interpretation of Data Derived from T cell-Based Immune Monitoring Assays
Cancer Research Institute

The Cancer Research Institute (CRI) and the Association for Cancer Immunotherapy (CIMT) announce the launch of a global, broad-based initiative to improve the reliability of reports of data derived from T cell-based immune monitoring assays, especially those used in the study of therapeutic vaccines for cancer and infectious diseases.

Released: 10-Nov-2009 8:30 AM EST
HPV Vaccine Clears Viral Infection and May Reduce Cancerous Lesions
Cancer Research Institute

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

Released: 16-Feb-2010 1:20 PM EST
Cancer Research Institute Young Philanthropists Announce Spring Event
Cancer Research Institute

Young philanthropists ages 21-40 gather on March 25, 2010, at Saks Fifth Avenue in NYC to raise funds for the Cancer Research Institute. Spring 2010 fashions on display, silent auction, and other prizes.

24-Feb-2010 9:30 PM EST
New Dimensions in the Analysis of the Immune Response to Cancer
Cancer Research Institute

Cancer researchers have taken a major step forward toward what is planned to be the most comprehensive analysis of the body’s antibody response to human cancer, an enterprise that has been termed “cancer seromics.”

Released: 24-Feb-2010 9:30 PM EST
CT45, an Unexpected Link Between Hodgkin Lymphoma and Reproductive Germ Cells
Cancer Research Institute

The laboratory of Dr. Lloyd J. Old of the Ludwig Institute for Cancer Research (LICR), together with Dr. Yao-Tseng Chen at Weill Cornell Medical College and their collaborators, made the finding that CT45, a cancer/testis (CT) antigen normally expressed in testicular germ cells in both prenatal and adult life, is expressed by the Reed-Sternberg cells in most of the classical Hodgkin lymphomas. The finding has implications for diagnostic, prognostic, and therapeutic approaches for Hodgkin lymphoma.

Released: 15-Mar-2010 6:00 AM EDT
Michael Kors, Andrew Witty to Receive 2010 Oliver R. Grace Award
Cancer Research Institute

Fashion Designer Michael Kors and GlaxoSmithKline Head Andrew Witty to Receive the 2010 Oliver R. Grace Award from the Cancer Research Institute (CRI) during CRI's 24th Annual Awards Dinner to be held June 16, 2010, at the Mandarin Oriental in New York City.

Released: 18-Mar-2010 4:30 PM EDT
Cancer Vaccine Consortium Changes Name to Cancer Immunotherapy Consortium
Cancer Research Institute

The Cancer Research Institute (CRI), a U.S.-based nonprofit organization that supports and coordinates laboratory and clinical efforts to harness the disease-fighting power of the immune system to treat, control, and prevent cancer, announced today that its program, the Cancer Vaccine Consortium—a leading global initiative on cancer vaccine research and development comprising industry, academia, and government institutions—has changed its name to the Cancer Immunotherapy Consortium (CIC).

Released: 7-Apr-2010 3:15 PM EDT
Scientists Develop Novel Technology to Assess Cancer Vaccine-Induced CD4+ T-cell Response
Cancer Research Institute

A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.

Released: 13-Apr-2010 4:30 PM EDT
28th Annual "Through the Kitchen" Event at The Four Seasons Restaurant
Cancer Research Institute

The 28th Annual "Through the Kitchen" Party at The Four Seasons Restaurant in New York City will take place Sunday, April 25, 2010. Proceeds benefit the Irvington Fellowship Program of the Cancer Research Institute.

Released: 30-Apr-2010 7:00 PM EDT
First FDA Approval of Therapeutic Cancer Vaccine A Milestone Victory for Field of Cancer Immunotherapy
Cancer Research Institute

Tumor immunologists are hailing the first FDA approval of a therapeutic cancer vaccine as a milestone victory, but many experts agree more research is needed to optimize cancer vaccines.

Released: 7-Jun-2010 9:00 AM EDT
Haruo Ohtani, Wolf Fridman, Jérôme Galon to Receive the 2010 William B. Coley Award from the Cancer Research Institute
Cancer Research Institute

The Cancer Research Institute bestows the 2010 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology upon three outstanding scientists at its upcoming 24th Annual Awards Dinner, to be held June 16, 2010, in New York City.

   
Released: 7-Jun-2010 3:00 PM EDT
Phase 3 Clinical Study of a New Cancer Immunotherapy Extends Survival in Patients with Refractory Melanoma
Cancer Research Institute

First treatment ever proven in a randomized trial to extend life for patients whose melanomas are unresponsive to existing cancer therapies.

Released: 22-Jul-2010 8:45 AM EDT
Cancer Research Institute Investigator Named to Top Position in U.K. Immunology Research Group
Cancer Research Institute

Cancer Research Institute, Inc. (CRI), celebrates yesterday’s announcement from the Medical Research Council that Vincenzo Cerundolo, M.D., Ph.D., has been named director of the MRC Human Immunology Unit (HIU) at the John Radcliffe Hospital in Oxford, U.K.

Released: 23-Sep-2010 12:20 PM EDT
Improving Endpoints for Cancer Immunotherapy Clinical Trials
Cancer Research Institute

Cancer Research Institute scientists recommend modifications to the clinical development paradigm to improve evaluation of immuotherapies for cancer.

Released: 22-Nov-2010 10:35 AM EST
U.S. and European Immunologists Publish Joint Position Paper On New Initiative to Improve Reliability and Interpretation of Data Derived from T Cell-Based Immune Monitoring Assays
Cancer Research Institute

Joint position paper by U.S. and European immunologists describing an international collaborative effort to arrive at minimal reporting requirements for T cell-based immune monitoring assays

Released: 14-Dec-2010 10:00 AM EST
Cancer Research Institute Announces Launch of Cancer Vaccine Acceleration Fund
Cancer Research Institute

New model of venture philanthropy aims to improve cancer patient care sooner by speeding development of highly promising cancer immunotherapies.

Released: 21-Jan-2011 6:00 AM EST
Cancer Research Institute Announces Second Investment from Its Cancer Vaccine Acceleration Fund to Enable Manufacture of Powerful Immune Stimulant
Cancer Research Institute

Cancer Research Institute, a nonprofit organization, has awarded $450,000 to Oncovir, Inc., to Produce and Supply Hiltonol® (Poly-ICLC) for Use in Clinical Trials of Cancer Vaccines and Other Immunotherapies.

Released: 9-Mar-2011 1:15 PM EST
Cancer Immunotherapy Consortium to Host Conference On Scheduling and Dosing for Combination Therapy
Cancer Research Institute

The Cancer Immunotherapy Consortium (CIC), a program of the nonprofit Cancer Research Institute, will host its 2011 Scientific Colloquium March 17-19, 2011, at the Gaylord National Hotel and Convention Center in National Harbor, MD. This year’s meeting, titled “Schedule and Dose for Combination Therapy,” will include a series of plenary lectures from academic and industry leaders in tumor immunology and immunotherapy.

Released: 25-Mar-2011 1:00 PM EDT
FDA Approves Ipilimumab, An Immunotherapy, To Treat Metastatic Melanoma
Cancer Research Institute

Yervoy (ipilimumab), a monoclonal antibody, received FDA approval today to treat advanced melanoma. This first-in-class antibody drug may also significantly improve standard cancer treatments.

Released: 25-Mar-2011 2:30 PM EDT
New Perspectives on Cancer and the Immune System
Cancer Research Institute

Three CRI scientists describe in this latest issue of Science magazine immunity’s paradoxical role in the promotion and control of cancer, a new understanding that places new treatments like ipilimumab (Yervoy) and sipuleucel-T (Provenge) within the context of 100 years of progress in tumor immunology and cancer immunotherapy.

Released: 14-Apr-2011 10:15 AM EDT
“Through the Kitchen” at the Four Seasons
Cancer Research Institute

Through The Kitchen is a themed benefit for the Irvington Institute Fellowship Program of the Cancer Research Institute, which supports young scientists in immunology and tumor immunology.

Released: 13-Jun-2011 3:55 PM EDT
Hollywood Producer and Cancer Activist Laura Ziskin Dies of Breast Cancer
Cancer Research Institute

Hollywood producer and cancer activist Laura Ziskin Dies of breast cancer. Cancer Research Institute to posthumously award Ziskin the 2011 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.

Released: 6-Jul-2011 11:40 AM EDT
Cancer Research Institute Awards $9.7 Million in Grantsto Support Immunology and Tumor Immunology Research
Cancer Research Institute

Cancer Research Institute announces $9.7 million in research funding for academic scientists in the fields of immunology and tumor immunology.


close
0.99711